Abbott settles antitrust allegations over TriCor

Abbott Laboratories stated in a regulatory filing that it intends to pay $184 million to settle class-action claims from pharmacies, wholesalers and generic-drug firms alleging that the company breached antitrust laws by working to block the launch of copies of its cholesterol drug TriCor. Abbott contends that it acted in accordance with the law and agreed to the settlement "to avoid the uncertainty of a trial outcome," a company spokeswoman said.

View Full Article in:

Wall Street Journal, The · Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR